薬剤比較
Tirzepatide vs Pioglitazone
Compare Tirzepatide (Mounjaro) vs Pioglitazone (Actos) for T2 diabetes. Dual GIP/GLP-1 agonist vs TZD: A1C, weight loss vs gain, CV risks, warnings.
このページには比較できる項目がありません。
臨床的背景
Type 2 diabetes patients comparing injectable dual incretin agonist tirzepatide against oral TZD pioglitazone for control, weight, and heart risks.
結論
Tirzepatide typically outperforms pioglitazone in A1C and weight loss for T2D but is injectable with GI effects.
すべての薬剤比較